Company Information

Revenue, expenses and profitability over five years.

Income Statement

SHREE GANESH REMEDIES LTD.

NSE Code: SGRLEQ
BSE Code: 540737
ISIN: INE414Y01015
Industry: Pharmaceuticals

Financial Data

Income Statement

All amounts are in ₹ crore unless stated otherwise.

Showing Standalone data

Five-year standalone Income Statement for the selected company
Particulars	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	108.09	106.50	124.80	90.22	71.29
Other Operating Revenues	1.19	2.09	1.09	0.00	0.00
Total Operating Revenues	109.29	108.60	125.90	90.22	71.29

Other Income	3.03	3.73	3.07	3.16	3.57
Total Revenue	112.32	112.33	128.96	93.38	74.86

EXPENSES
Cost Of Materials Consumed	40.92	37.38	61.05	47.83	37.42
Purchase Of Stock-In Trade	0.00	0.01	1.28	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	0.96	-1.52	-4.88	-0.69	-0.40
Employee Benefit Expenses	11.40	10.12	8.41	5.87	4.73
Finance Costs	3.56	2.08	0.60	0.12	0.15
Depreciation And Amortisation Expenses	10.47	9.57	6.11	3.72	3.34
Other Expenses	20.99	23.39	18.23	13.95	11.61
Total Expenses	88.30	81.03	90.79	70.80	56.85

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	24.01	31.30	38.17	22.58	18.01

Profit/Loss Before Tax	24.01	31.30	38.17	22.58	18.01

Tax Expenses-Continued Operations
Current Tax	5.65	8.05	9.33	5.85	4.65
Deferred Tax	0.53	-0.04	0.67	-0.28	-0.04
Tax For Earlier Years	0.06	0.20	0.04	0.00	0.00
Total Tax Expenses	6.24	8.20	10.05	5.56	4.61
Profit/Loss After Tax And Before ExtraOrdinary Items	17.77	23.10	28.12	17.02	13.40

Profit/Loss From Continuing Operations	17.77	23.10	28.12	17.02	13.40

Profit/Loss For The Period	17.77	23.10	28.12	17.02	13.40

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	13.84	17.98	22.35	13.86	11.16
Diluted EPS (Rs.)	13.84	17.98	22.35	13.86	11.16

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	0.00	0.63	0.60	1.75
Tax On Dividend	0.00	0.00	0.00	0.08	0.08
Equity Dividend Rate (%)	0.00	0.00	0.00	5.00	5.00

Five-year consolidated Income Statement for the selected company
Particulars	Mar 26	Mar 25	Mar 24	Mar 20	Mar 19
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	108.09	106.50	124.80	64.02	35.31
Other Operating Revenues	1.19	2.09	1.09	0.00	0.00
Total Operating Revenues	109.29	108.60	125.90	64.02	35.31

Other Income	3.03	3.73	3.07	3.91	1.17
Total Revenue	112.32	112.33	128.96	67.93	36.48

EXPENSES
Cost Of Materials Consumed	40.92	37.38	61.05	38.31	20.48
Purchase Of Stock-In Trade	0.00	0.01	1.28	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	0.96	-1.52	-4.88	-0.39	-1.98
Employee Benefit Expenses	11.40	10.12	8.41	3.99	2.11
Finance Costs	3.56	2.11	0.61	0.54	0.20
Depreciation And Amortisation Expenses	10.47	9.57	6.11	2.29	1.04
Other Expenses	20.99	23.39	18.23	9.60	5.97
Total Expenses	88.30	81.06	90.80	54.34	27.81

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	24.01	31.27	38.16	13.59	8.67

Profit/Loss Before Tax	24.01	31.27	38.16	13.59	8.67

Tax Expenses-Continued Operations
Current Tax	5.66	8.05	9.33	3.18	2.19
Deferred Tax	0.53	-0.04	0.67	-0.06	0.24
Tax For Earlier Years	0.06	0.20	0.04	0.00	0.00
Total Tax Expenses	6.26	8.20	10.05	3.12	2.43
Profit/Loss After Tax And Before ExtraOrdinary Items	17.76	23.07	28.11	10.47	6.24

Profit/Loss From Continuing Operations	17.76	23.07	28.11	10.47	6.24

Profit/Loss For The Period	17.76	23.07	28.11	10.47	6.24
Consolidated Profit/Loss After MI And Associates	17.76	23.07	28.11	10.47	6.24

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	13.83	17.96	22.34	11.67	6.95
Diluted EPS (Rs.)	13.83	17.96	22.34	11.67	6.95

DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend	0.00	0.00	0.63	1.35	1.08

Source: Financial statements as reported by the company.